Millennium Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-16,100
Closed -$696K 4067
2015
Q3
$696K Sell
16,100
-416,317
-96% -$17.6M ﹤0.01% 2480
2015
Q2
$18.3M Sell
432,417
-429,955
-50% -$18.1M 0.03% 673
2015
Q1
$33.4M Buy
862,372
+839,907
+3,739% +$32.3M 0.06% 408
2014
Q4
$756K Sell
22,465
-235,818
-91% -$8.33M ﹤0.01% 2698
2014
Q3
$9.04M Buy
258,283
+166,109
+180% +$5.69M 0.02% 923
2014
Q2
$3.03M Buy
+92,174
New +$3.15M 0.01% 1509
2013
Q4
Sell
-125,000
Closed -$3.42M 4038
2013
Q3
$3.42M Sell
125,000
-22,036
-15% -$522K 0.01% 1333
2013
Q2
$3.09M Buy
+147,036
New +$2.87M 0.01% 1313

Other funds holding WX

Millennium Management's WX Position: Q4 2015 in Review

Millennium Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 16,100 shares — an estimated $696K sold.

Millennium Management first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $33.4M in Q1 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Millennium Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Millennium Management sold 16,100 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $696K.
  • Millennium Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
  • Millennium Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $33.4M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Millennium Management's 13F filing for Q4 2015, filed 16 Feb 2016.